Top compounds associated with response to LIX1L


Feature Type Standardized
Nominal ANOVA
mRNA AZD0530 CCLE pan-cancer AAC -0.11 0.05
mRNA 968 CTRPv2 pan-cancer AAC -0.15 0.05
mRNA nelarabine CTRPv2 pan-cancer AAC 0.088 0.05
mRNA Rapamycin gCSI pan-cancer AAC 0.12 0.05
mRNA MLN4924 GDSC1000 pan-cancer AAC 0.086 0.05
mRNA manumycin A CTRPv2 pan-cancer AAC 0.074 0.05
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.082 0.06
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.11 0.06
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.06
Download CSV